GlobalData on MSN16d
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
Whilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.
Hosted on MSN12d
Rift Valley Fever Vaccine : Hope as South African Company Joins Effort
By Gift Briton Global efforts for a Rift Valley fever (RVF) vaccine accelerate as South Africa’s Afrigen Biologics begins local development of mRNA vaccine.With no vaccine approved for human use yet, ...